BCL-6 mutations in normal germinal center B cells: Evidence of somatic hypermutation acting outside Ig loci
-
- Laura Pasqualucci
- Departments of Pathology and Genetics and Development, Columbia University, New York, NY 10032; Servizio di Ematologia, Istituto di Scienze Mediche, Universita’ di Milano, Ospedale Maggiore Istituto di Ricoveroe Cura a Carattere Scientifico, Milan 20122, Italy; Department of Human Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021; and Institute of Genetics, University of Cologne, Cologne 50931, Germany
-
- Anna Migliazza
- Departments of Pathology and Genetics and Development, Columbia University, New York, NY 10032; Servizio di Ematologia, Istituto di Scienze Mediche, Universita’ di Milano, Ospedale Maggiore Istituto di Ricoveroe Cura a Carattere Scientifico, Milan 20122, Italy; Department of Human Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021; and Institute of Genetics, University of Cologne, Cologne 50931, Germany
-
- Christopher William
- Departments of Pathology and Genetics and Development, Columbia University, New York, NY 10032; Servizio di Ematologia, Istituto di Scienze Mediche, Universita’ di Milano, Ospedale Maggiore Istituto di Ricoveroe Cura a Carattere Scientifico, Milan 20122, Italy; Department of Human Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021; and Institute of Genetics, University of Cologne, Cologne 50931, Germany
-
- R. S. K. Chaganti
- Departments of Pathology and Genetics and Development, Columbia University, New York, NY 10032; Servizio di Ematologia, Istituto di Scienze Mediche, Universita’ di Milano, Ospedale Maggiore Istituto di Ricoveroe Cura a Carattere Scientifico, Milan 20122, Italy; Department of Human Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021; and Institute of Genetics, University of Cologne, Cologne 50931, Germany
-
- Ulf Klein
- Departments of Pathology and Genetics and Development, Columbia University, New York, NY 10032; Servizio di Ematologia, Istituto di Scienze Mediche, Universita’ di Milano, Ospedale Maggiore Istituto di Ricoveroe Cura a Carattere Scientifico, Milan 20122, Italy; Department of Human Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021; and Institute of Genetics, University of Cologne, Cologne 50931, Germany
-
- Ralf Küppers
- Departments of Pathology and Genetics and Development, Columbia University, New York, NY 10032; Servizio di Ematologia, Istituto di Scienze Mediche, Universita’ di Milano, Ospedale Maggiore Istituto di Ricoveroe Cura a Carattere Scientifico, Milan 20122, Italy; Department of Human Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021; and Institute of Genetics, University of Cologne, Cologne 50931, Germany
-
- Klaus Rajewsky
- Departments of Pathology and Genetics and Development, Columbia University, New York, NY 10032; Servizio di Ematologia, Istituto di Scienze Mediche, Universita’ di Milano, Ospedale Maggiore Istituto di Ricoveroe Cura a Carattere Scientifico, Milan 20122, Italy; Department of Human Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021; and Institute of Genetics, University of Cologne, Cologne 50931, Germany
-
- Riccardo Dalla-Favera
- Departments of Pathology and Genetics and Development, Columbia University, New York, NY 10032; Servizio di Ematologia, Istituto di Scienze Mediche, Universita’ di Milano, Ospedale Maggiore Istituto di Ricoveroe Cura a Carattere Scientifico, Milan 20122, Italy; Department of Human Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021; and Institute of Genetics, University of Cologne, Cologne 50931, Germany
説明
<jats:p>The molecular mechanism involved in the process of antigen-driven somatic hypermutation of Ig genes is unknown, but it is commonly believed that this mechanism is restricted to the Ig loci. B cell lymphomas commonly display multiple somatic mutations clustering in the 5′-regulatory region of BCL-6, a proto-oncogene encoding for a POZ/Zinc finger transcriptional repressor expressed in germinal center (GC) B cells and required for GC formation. To determine whether BCL-6 mutations represent a tumor-associated phenomenon or reflect a physiologic mechanism, we screened single human tonsillar GC B cells for mutations occurring in the BCL-6 5′-noncoding region and in the Ig variable heavy chain sequences. Thirty percent of GC B cells, but not naive B cells, displayed mutations in the 742 bp region analyzed within the first intron of BCL-6 (overall frequency: 5 × 10<jats:sup>−4</jats:sup>/bp). Accordingly, an expanded survey in lymphoid malignancies showed that BCL-6 mutations are restricted to B cell tumors displaying GC or post-GC phenotype and carrying mutated Ig variable heavy chain sequences. These results indicate that the somatic hypermutation mechanism active in GC B cells physiologically targets non-Ig sequences.</jats:p>
収録刊行物
-
- Proceedings of the National Academy of Sciences
-
Proceedings of the National Academy of Sciences 95 (20), 11816-11821, 1998-09-29
Proceedings of the National Academy of Sciences
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1362544418685926656
-
- NII論文ID
- 80010684061
-
- ISSN
- 10916490
- 00278424
- http://id.crossref.org/issn/00278424
-
- データソース種別
-
- Crossref
- CiNii Articles